Rai S, Kim WS, Ando K, Choi I, et al. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results. Haematologica 2024 Jun 6. doi: 10.3324/haematol.2023.283992.
PMID: 38841789